3.03
price down icon1.79%   -0.05
 
loading
前日終値:
$3.08
開ける:
$3.09
24時間の取引高:
94,673
Relative Volume:
0.58
時価総額:
$202.34M
収益:
-
当期純損益:
$-64.20M
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
$57,000
1週間 パフォーマンス:
-5.32%
1か月 パフォーマンス:
-36.98%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$2.90
$3.1199
1週間の範囲:
Value
$2.90
$3.355
52週間の値動き範囲:
Value
$2.90
$5.47

Climb Bio Inc Stock (CLYM) Company Profile

Name
名前
Climb Bio Inc
Name
セクター
Healthcare (1195)
Name
電話
1-866-857-2596
Name
住所
20 WILLIAM STREET, WELLESLEY HILLS
Name
職員
11
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
CLYM's Discussions on Twitter

CLYM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CLYM 3.03 202.34M 0 -64.20M 57,000 0.00
VRTX 448.45 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.78 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 587.26 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.71 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.50 24.89B 3.30B -501.07M 1.03B 11.54

Climb Bio Inc (CLYM) 最新ニュース

pulisher
12:33 PM

Are Wall Street Analysts Predicting Bio-Techne Stock Will Climb Or Sink? - Barchart

12:33 PM
pulisher
Nov 20, 2024

Some Confidence Is Lacking In ABL Bio Inc. (KOSDAQ:298380) As Shares Slide 30% - Simply Wall St

Nov 20, 2024
pulisher
Nov 15, 2024

Are Wall Street Analysts Predicting KKR Stock Will Climb or Sink? - MSN

Nov 15, 2024
pulisher
Nov 14, 2024

Deep Track Capital, LP Reduces Stake in Climb Bio Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Are Business Services Stocks Lagging Climb Global Solutions, Inc. (CLMB) This Year? - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Sri Lankan Stocks Climb, Information Technology Leads The Way - Finimize

Nov 14, 2024
pulisher
Nov 13, 2024

Climb Bio Inc. Shifts Focus to Immune-Mediated Diseases - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

iBio Reports Fiscal First Quarter 2025 Financial Results - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Climb Bio Secures FDA Clearance for SLE Drug Trial, Reports $217.9M Cash Position | CLYM Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

Climb Bio Appoints Biotech Veteran Douglas Williams as Board Chair, Strengthens Leadership | CLYM Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 06, 2024

Sales climb for EcoSynthetix Inc. in Q3 - Pulp & Paper Canada

Nov 06, 2024
pulisher
Oct 31, 2024

Climb Bio to Present at Upcoming Investor Conferences - GlobeNewswire

Oct 31, 2024
pulisher
Oct 30, 2024

Nasdaq Futures Climb on Upbeat Alphabet Results, U.S. GDP Data and More Big Tech Earnings on Tap - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

Humic Acid Market Set to Climb to USD 1.63 Billion by 2030 - openPR

Oct 30, 2024
pulisher
Oct 24, 2024

ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN

Oct 24, 2024
pulisher
Oct 23, 2024

Tevogen Bio (TVGN) Sees Major Stock Surge After Key AI Move - Stocks Telegraph

Oct 23, 2024
pulisher
Oct 19, 2024

Interpublic Group Of Cos., Inc. (IPG): Worth A Small Bite At $32.03 - Stocks Register

Oct 19, 2024
pulisher
Oct 18, 2024

Why Lamb Weston Stock Was Climbing Today - Yahoo Finance

Oct 18, 2024
pulisher
Oct 18, 2024

Big Bank Stocks Climb. 3 Stocks to Consider Adding to Your Portfolio. - Yahoo Finance

Oct 18, 2024
pulisher
Oct 18, 2024

Merck & Co’s Clesrovimab Has Beyfortus Hill To Climb In RSV - Citeline News & Insights

Oct 18, 2024
pulisher
Oct 17, 2024

Treasury Yields Climb as Strong Data Sow Doubt on Fed Rate Cuts - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Mortgage Demand Sees Sharpest Weekly Drop Since April 2020 As Rates Climb Above 6.5% - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Korean growth stocks climb after rate cut - 코리아타임스

Oct 17, 2024
pulisher
Oct 16, 2024

Vale Achieves Six-Year High in Iron Ore Output, Copper and Nickel Production Also Climb - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

European Wax Center Continues to Climb in Franchise Times' Top 400 Ranking - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

US Mortgage Rates Climb to 6.52%, Highest Since Early August - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

What You Need to Know Ahead of Bio-Techne's Earnings Release - TradingView

Oct 16, 2024
pulisher
Oct 15, 2024

Stocks of B. Riley Financial Inc (RILY) are poised to climb above their peers - SETE News

Oct 15, 2024
pulisher
Oct 15, 2024

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event - The Manila Times

Oct 15, 2024
pulisher
Oct 14, 2024

‘Retirement super pot’ holders pay themselves around £3m each in a year - Yahoo Finance UK

Oct 14, 2024
pulisher
Oct 12, 2024

Climb Bio to present kidney disease treatment study By Investing.com - Investing.com Australia

Oct 12, 2024
pulisher
Oct 12, 2024

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024 - GlobeNewswire

Oct 12, 2024
pulisher
Oct 11, 2024

Climb Bio to present kidney disease treatment study - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology - The Bakersfield Californian

Oct 11, 2024
pulisher
Oct 11, 2024

A stock that deserves closer examination: Climb Bio Inc. (CLYM) - US Post News

Oct 11, 2024
pulisher
Oct 10, 2024

Climb Global (CLMB) Surged on Strong Results - Yahoo Finance

Oct 10, 2024
pulisher
Oct 09, 2024

Quarterly IPOs Climb Back Above $1bn - Scrip

Oct 09, 2024
pulisher
Oct 09, 2024

US 30-Year Mortgage Rate Climbs by Most in More Than a Year - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Climb Global (CLMB) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance

Oct 08, 2024
pulisher
Oct 04, 2024

FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77% - Baystreet.ca

Oct 04, 2024
pulisher
Oct 04, 2024

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - ForexTV.com

Oct 04, 2024
pulisher
Oct 04, 2024

Climb Bio to Present at William Blair’s Upcoming Conference - GlobeNewswire

Oct 04, 2024
pulisher
Oct 04, 2024

Climb Bio to Present at William Blair's Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - The Manila Times

Oct 04, 2024
pulisher
Oct 03, 2024

Intumescent Coatings Market Size to Climb to USD 2.4 - GlobeNewswire

Oct 03, 2024
pulisher
Oct 03, 2024

Intumescent Coatings Market Size to Climb to USD 2.4 billion by 2034 with a 7.4% CAGR, Supported by Steel Fabrication Fireproofing Demand | States Transparency Market Research, Inc. - Yahoo Finance

Oct 03, 2024

Climb Bio Inc (CLYM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Climb Bio Inc (CLYM) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Morisset Valerie
EVP, R&D AND CSO
Jul 22 '24
Sale
8.03
69,005
554,170
31,317
Morisset Valerie
EVP, R&D AND CSO
Jul 19 '24
Sale
7.21
60,201
434,325
100,322
Morisset Valerie
EVP, R&D AND CSO
Jul 18 '24
Sale
6.93
38,576
267,332
160,523
Morisset Valerie
EVP, R&D AND CSO
Jul 17 '24
Sale
6.91
3,207
22,160
199,099
Morisset Valerie
EVP, R&D AND CSO
Jul 16 '24
Sale
7.13
50,000
356,500
202,306
Morisset Valerie
EVP, R&D AND CSO
Jul 12 '24
Sale
7.07
50,000
353,500
294,683
Morisset Valerie
EVP, R&D AND CSO
Jul 15 '24
Sale
7.01
42,377
297,063
252,306
Morisset Valerie
EVP, R&D AND CSO
Jul 11 '24
Sale
7.11
50,000
355,500
344,683
Morisset Valerie
EVP, R&D AND CSO
Jul 10 '24
Sale
6.83
50,000
341,500
394,683
Morisset Valerie
EVP, R&D AND CSO
Jul 09 '24
Sale
6.66
5,931
39,500
444,683
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):